BioSpace News Archive

Press Releases

New England Journal of Medicine Publishes: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer

February 5, 2025
·
13 min read
Press Releases

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

February 5, 2025
·
2 min read
Press Releases

Quince Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

February 5, 2025
·
1 min read
Press Releases

Hologic Announces Financial Results for First Quarter of Fiscal 2025

February 5, 2025
·
21 min read
Press Releases

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

February 5, 2025
·
13 min read
Press Releases

New England Journal of Medicine Publishes Results of Global, Multicenter eNRGy Study Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer

February 5, 2025
·
10 min read
Press Releases

Turn Therapeutics Achieves 24-Hour Stability for Live Vaccine in Intranasal Oil Suspension at Room Temperature, Marking Major Milestone Toward Improving Vaccine Access

February 5, 2025
·
3 min read
Press Releases

Akeso Announces the Completion of Patient Enrollment in the Phase III Clinical Trial (HARMONi-6) Comparing Ivonescimab and Tislelizumab for First-Line Treatment of Sq-NSCLC

February 5, 2025
·
3 min read
Press Releases

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - February 5, 2025

February 5, 2025
·
2 min read
Press Releases

Belite Bio Announces Registered Direct Offering of $15 Million

February 5, 2025
·
3 min read